What is iluvien used for?

Indication: ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg is indicated for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure.

How much does iluvien cost?

The cost for Iluvien intravitreal implant 0.19 mg is around $9,276 for a supply of 1 implant, depending on the pharmacy you visit.

Does iluvien dissolve?

Iluvien Implant Description The drug substance is a synthetic corticosteroid, fluocinolone acetonide. Fluocinolone acetonide is a white or almost white, microcrystalline powder, practically insoluble in water, soluble in methanol, ethanol, chloroform and acetone, and sparingly soluble in ether.

Who makes iluvien?

(NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the development and commercialization of prescription ophthalmic pharmaceuticals, announces that Alimera Sciences Europe Limited, its Irish subsidiary, has launched ILUVIEN® in the Netherlands.

Is ILUVIEN a steroid?

The medicine in ILUVIEN is called fluocinolone acetonide (FAc), a type of steroid called a corticosteroid. FAc helps treat the inflammation associated with diabetic macular edema (DME).

What cures ILUVIEN?

What is Iluvien? Fluocinolone ophthalmic (for the eye) implant is a steroid medicine that is used to treat diabetic macular edema, a build-up of fluid in the retina that is caused by leaking blood vessels. Iluvien is also used to treat posterior uveitis, inflammation that affects the back of the eye.

How is ILUVIEN administered?

The implant is a tiny tube measuring approximately 3.5 mm x 0.37 mm in size and is administered via a custom applicator with a 25-gauge needle. Not actual size.

When was iluvien approved?

September 26, 2014
On September 26, 2014, The US Food and Drug Administration approved ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular …

What is diabetic macular edema?

Macular edema occurs when there is abnormal leakage and accumulation of fluid in the macula from damaged blood vessels in the nearby retina. A common cause of macular edema is diabetic retinopathy, a disease that can happen to people with diabetes.

When was ILUVIEN approved?

How often is ILUVIEN given?

The tiny ILUVIEN implant is inserted into the eye and remains in the eye for continuous drug delivery. It is the only FDA-approved implant that delivers steroid for 36 months.

Is iluvien FDA approved?

On September 26, 2014, The US Food and Drug Administration approved ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular …